Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2026-02-20 @ 5:28 PM
Study NCT ID:
NCT04241835
Status:
RECRUITING
Last Update Posted:
2025-11-14
First Post:
2019-12-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function
Sponsor:
Epizyme, Inc.
Organization: